Dimensional Fund Advisors
TYRA icon

Dimensional Fund Advisors’s Tyra Biosciences TYRA Stock Holding History

Dimensional Fund Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.19M Buy
328,962
+111,884
+52% +$3.08M ﹤0.01% 2391
2026
Q2 		$6.93M Buy
217,078
+125,252
+136% +$4.14M ﹤0.01% 2443
2026
Q1 		$3.52M Sell
91,826
-3,814
-4% -$123K ﹤0.01% 2594
2025
Q4 		$2.51M Buy
95,640
+55,961
+141% +$1.03M ﹤0.01% 2690
2025
Q3 		$555K Sell
39,679
-2,002
-5% -$22.8K ﹤0.01% 2977
2025
Q2 		$399K Buy
41,681
+6,969
+20% +$66.2K ﹤0.01% 3027
2025
Q1 		$323K Sell
34,712
-3,269
-9% -$42.3K ﹤0.01% 3064
2024
Q4 		$528K Buy
37,981
+28,074
+283% +$509K ﹤0.01% 3028
2024
Q3 		$233K Buy
+9,907
New +$208K ﹤0.01% 3145
2024
Q2 		– Sell
-10,750
Closed -$176K – 3412
2024
Q1 		$176K Buy
10,750
+141
+1% +$2.31K ﹤0.01% 3202
2023
Q4 		$147K Hold
10,609
– – ﹤0.01% 3240
2023
Q3 		$146K Buy
10,609
+8
+0.1% +$119 ﹤0.01% 3265
2023
Q2 		$181K Buy
+10,601
New +$154K ﹤0.01% 3252

Other funds holding TYRA

Canaan Partners XI
Canaan Partners XI Menlo Park, California $66.9M AUM 86.25% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Auour Investments
Auour Investments Woburn, Massachusetts $353M AUM 8.66% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Dimensional Fund Advisors's TYRA Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Tyra Biosciences (TYRA) stake by 52% in Q3 2026, buying an estimated $3.08M and bringing the position to 328,962 shares worth $7.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2391.

Dimensional Fund Advisors first reported a position in TYRA in Q2 2023 and has held it in 13 quarters since. 33 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Dimensional Fund Advisors held 328,962 shares of Tyra Biosciences worth $7.19M as of Q3 2026.
  • Dimensional Fund Advisors bought 111,884 Tyra Biosciences shares in Q3 2026, an estimated $3.08M.
  • Tyra Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2391 holding.
  • Dimensional Fund Advisors first reported a position in Tyra Biosciences in Q2 2023 and has held it in 13 quarters since.
  • 33 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.